Milestone Pharmaceuticals, Inc. (MIST)
0.52
-0.14
(-20.63%)
USD |
NASDAQ |
Nov 13, 16:00
0.505
-0.02
(-2.88%)
After-Hours: 19:59
Milestone Pharmaceuticals Net Income (Quarterly) : -25.80M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -25.80M |
| June 30, 2026 | -28.61M |
| March 31, 2026 | -26.07M |
| December 31, 2025 | -17.41M |
| September 30, 2025 | -11.92M |
| June 30, 2025 | -12.97M |
| March 31, 2025 | -20.76M |
| December 31, 2024 | -12.36M |
| September 30, 2024 | -9.439M |
| June 30, 2024 | -9.363M |
| March 31, 2024 | -10.35M |
| December 31, 2023 | -13.61M |
| September 30, 2023 | -15.08M |
| June 30, 2023 | -16.04M |
| March 31, 2023 | -14.95M |
| December 31, 2022 | -13.18M |
| Date | Value |
|---|---|
| September 30, 2022 | -14.56M |
| June 30, 2022 | -16.65M |
| March 31, 2022 | -14.01M |
| December 31, 2021 | -16.88M |
| September 30, 2021 | -14.22M |
| June 30, 2021 | 0.77M |
| March 31, 2021 | -12.51M |
| December 31, 2020 | -8.666M |
| September 30, 2020 | -11.98M |
| June 30, 2020 | -12.98M |
| March 31, 2020 | -16.34M |
| December 31, 2019 | -18.29M |
| September 30, 2019 | -12.83M |
| June 30, 2019 | -13.66M |
| March 31, 2019 | -10.45M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| NervGen Pharma Corp. | 7.803M |
| Appili Therapeutics, Inc. | -1.314M |
| Clearmind Medicine, Inc. | -0.9073M |
| Lexaria Bioscience Corp. | -1.993M |
| Target Group, Inc. (Canada) | -0.2398M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.963M |
| Total Expenses (Quarterly) | 28.76M |
| EPS Diluted (Quarterly) | -0.1831 |
| Enterprise Value | 63.15M |
| Gross Profit Margin (Quarterly) | 87.11% |
| Profit Margin (Quarterly) | -870.6% |
| Earnings Yield | -144.9% |
| Normalized Earnings Yield | -144.87 |